
At LyoDx, we believe that meaningful progress in diagnostics is only possible through strong, collaborative partnerships. We are looking for multi-sector collaborations with clinicians, researchers, public health organisations and industry partners to develop and evaluate molecular diagnostics that address unmet needs, particularly in the field of tuberculosis.
We support the commercialisation of innovative assays through lyophilisation and workflow optimisation, creating simple, stable and reliable diagnostic products, available where they are needed most.

Clinical and Academic Partners
Including hospitals, universities and research institutes interested in evaluating novel molecular assays, generating clinical evidence or contributing to translational research.
Public Health and TB Programmes
National and regional TB programmes, NGOs and global health organisations to support diagnostic evaluation in diverse settings.
Industry and Technology Partners
Fellow organisations within the diagnostics and wider biotechnology industry to support assay development, workflow optimisation and automation.
Funders and Consortia
Participating in grant-funded and consortium-based projects can help advance diagnostic innovation and access.

.png/:/cr=t:12.5%25,l:0%25,w:100%25,h:75%25/rs=w:600,h:300,cg:true)
If you are interested in collaborating with LyoDx, whether to evaluate TB-HIRA, explore new applications of molecular diagnostics, or develop joint research initiatives, please get in touch using the link below.